Financing channel feed – Endpoints News

SIGN UP

Financing channel feed

Pharvaris soars on mid-stage data for severe swelling condition, raises $300M

16 hours ago

Scoop: Infectious disease biotech eyes $25M Series A to advance antibody for chronic lung infection

Yesterday

Exclusive: Gary Glick’s Odyssey raises $101M Series C as first immunology drugs approach the clinic

Yesterday

Seismic raises $121M to enter immunology space spotlighted by argenx, Immunovant and others

2 days ago

Exclusive: San Diego biotech raises $11.7M to use cells as targeted delivery vessels for genetic medicines

5 days ago

ARCH-allied AN Venture Partners raises $200M to build biotechs out of research from Japan

5 days ago

Small transpacific team led by Lilly, Everest vet turns to computational tools for next wave of peptide drug discovery

6 days ago

Cell manufacturing company raises $19M Series A to increase capacity, staff numbers

6 days ago

Exclusive: Novo foundation's growth arm is making an investment push into healthcare, expanding beyond life sciences

6 days ago

Xenon offers $300M in shares after touting path ahead for MDD program despite PhII miss

6 days ago

Health tech stands out as a top area for early-stage VC funding in Q3

Last week

Arrivo bags $45M Series B to fund major depression late-stage test and PhII-ready pancreatitis asset

Last week

Verve raises $148M via public stock offering, private placement with Eli Lilly (corrected)

Last week

Early-stage healthcare startups are facing a funding cliff

Last week

European AI startup raises $24M for protein design software service

Last week

Arvinas gets $350M boost from investors to extend runway into 2027

Last week

Khosla Ventures leads $38M seed round for organoid startup Vivodyne

2 weeks ago

Flagship launches first UK-based startup to uncover genes that make cells vulnerable or resistant to disease

3 weeks ago

Former college roommates combine health and tech backgrounds to raise $58M for new fund

3 weeks ago

Obesity and diabetes biotech Carmot Therapeutics files for IPO

3 weeks ago

Biotech’s IPO outlook for the rest of the year sours in wake of war, broader industry struggles

3 weeks ago

Scoop: Rakuten Medical targets year-end close for $100M+ Series E to fund photoimmunotherapy pipeline: #Jefferies23

3 weeks ago

Scoop: CellProthera eyes $30M round for PhIII trial of cell therapy for heart attacks: #Jefferies23

3 weeks ago

NMD Pharma secures €75M from insiders for three PhII trials in neuromuscular disorders

3 weeks ago

12 3 4 Next page Last page